The Office of Extramural Research (OER) has a comprehensive list of Frequently Asked Questions for the SBIR and STTR programs. Many of the questions that investigators ask can be found on this list. Additional questions that are specific to NINDS can be found below.
NINDS is interested in small business applications that fall within the mission of the institute. While NINDS has specific funding opportunities, found on the NINDS Small Business Funding Opportunities page, many of our applications are investigator initiated and come in through the general omnibus solicitation. Please contact program staff if you have questions about which institute(s) would be the best fit for your project.
The success rates of both the SBIR and STTR programs depend on the budget and the number of applications and can fluctuate from year to year. While the STTR budget is significantly smaller, historically the program gets far fewer applications. Applicants are encourage to read about both programs and pick the one that best fits their project.
NINDS accepts SBIR and STTR clinical trial application through specific opportunities found on the NINDS Small Business Funding Opportunities page. Applications containing clinical trials are no longer accepted through the general omnibus solicitations. In addition, NINDS now requires authorization from the Food and Drug Administration (FDA) to use an investigation drug, biologic product or device in a clinical trial prior to the submission of an application. Please see notice NOT-NS-11-018 for more information.
NINDS accepts Phase IIB SBIR/STTR Competing Renewal applications through specific opportunities, found on the NINDS Small Business Funding Opportunities page. Phase IIB applications are no longer accepted through the general omnibus solicitations.
Yes, but it must be well justified in the application. NINDS may decrease the length of an award, amount of an award, or not fund an application for budgetary or programmatic reasons. Generally, NINDS does not Phase I applications greater than $350,000 total cost per year for up to 2 years or Phase II applications greater than $1,000,000 total cost per year for up to 3 years. Applicants considering a requested budget greater than these limits are strongly encouraged to contact program staff before submitting an application.
In general, grantees own the rights to data and inventions resulting from any grant-supported project. NIH may use march-in rights only if an awardee fails to achieve practical application of an invention. However, NIH has never exercised this right because of the lengthy administrative process.
Check with your grants management specialist to determine if they are waiting on a specific piece of information. NINDS will not release the Notice of Grant Award (NGA) until all requested documentation has been received and all requirements completed. Please see the Award Information page for more details.
Last updated May 14, 2013